The missing data layer between AI and matter. Now available.
Giving R&D teams access to the next fundamental data class revealing how molecules, formulations, and materials truly behave under real-world conditions.
.svg)
.svg)
.svg)
.svg)
How to work with us
From focus pilot to a proprietary behavioural data advantage.
Program pilot
A defined set of molecules from an active program, measured on our platform and benchmarked against your internal controls. Receive proof of value on your own candidates.
Program partnership
Standardised behavioural embeddings and datasets designed for internal ML use including compatibility with your existing sequence and structure models.
Strategic data partnership
Access your own proprietary behavioural data layer that compounds with every measurement - building an advantage competitors cannot replicate.
Academic Partnerships
We actively partner with academic institutions around the world to collaboratively push the field forward.
.svg)
.svg)
.svg)
.svg)
Measure a new dimension of molecular data.
“... Apoha’s Liquid Brain can distinguish between different classes of oils, including those that are chemically similar in composition …Further, the readings from Apoha’s signatures correlated with the independent biophysical property measurements. … This technology can therefore help design sensorially similar or superior formulations and reduce / remove dependence on customer testing to validate the degree of similarity. This could be commercially significant, potentially reducing product failure rates, and the product testing cycle from several months to days.”
Head of R&D
Major Indian FMCG Company
"Apoha unlocked a characterization space for clinically relevant serum samples. We saw clear signals that can boost the predictive power of our models and contribute to disease diagnosis - signals we cannot feasibly capture otherwise."
Tristan Deli, PhD
Co-founder, CTO
“Apoha’s platform is exactly the type of technology that regulators are pushing for and the industry is looking for… fingerprint-like analytical data, multidimensional, relating structure to function.”
Rafiq Islam
President
“We’ve never had a method that shows this level of separation across tea types based purely on biophysics. It gave us the clarity to prioritise which blends to advance and which to revisit - all without needing another consumer panel.”
Director of Innovation
Major UK Beverage Company
"We chose Apoha because conventional assays just down show this data. We’re now integrating Apoha’s platform at the very start of our next program."
Estelle Beguin, PhD
Director Technology Research
"We’ve now worked with Apoha across multiple pilot programs, including a recent 70-antibody case study on a novel modality. In one early study, Liquid Brain correctly flagged liabilities between antibodies that differed by just 1–2 amino acids! Based on these results, we’re now integrating Liquid Brain at the very start of our next program to get developability insights right at hit identification."
Michael Marlow, PhD
Director, Biologics
“We gave >20 proteins for Apoha to characterise, which would have taken months through the traditional methods, and would have come at a high cost for renting specific equipment. Apoha did it in a couple of days! Apoha’s insights enabled us to formulate a new product in record time – their proprietary feature vectors provided direct comparison of proteins and their interchangeability. We achieved in days what usually takes months...”
Head of Innovation
UK Alternative Food Protein Company
"Apoha’s platform works with practically no materials - the biggest limitation at early stages - and it not only lets us detect liabilities earlier but also gives us additional insights beyond everything else we already have. That makes it incredibly easy to adopt into our workflow. I’m excited to continue to work with Apoha at a larger scale."
Nimish Gera, PhD
Scientific Co-Founder, VP